$290KIndia’s exports in FY 2025-26
8countries bought from India
+71%against FY 2024-25 ($170K)
16tonnes shipped in FY 2025-26
India’s exports, year by year
US$, Indian financial years (April–March). Source: DGCI&S, Ministry of Commerce (Tradestat).
Biggest buyers, FY 2025-26
- Angola
- Mozambique
- Namibia
- Kenya
- Tajikistan
- Zambia
- Congo (DRC)
- Tanzania
Ranked by value. Country-by-country figures are not shown.
GST on this code
5%
- 5% — Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, including Ayurvedic, Unani, homoeopathic siddha or Bio-chemic systems medicaments, put up for retail saleNotification 9/2025-CT(R), Schedule I, entry 234
GST on supply within India, as of 1 May 2026. Exports are zero-rated supplies.
Other codes in 3004.20
3004.20.19Medicaments — containing other antibiotics, cephalosporins and their derivatives: Other$350M in FY 2025-263004.20.99Medicaments — containing other antibiotics, other: Other$277M in FY 2025-263004.20.64Medicaments — containing other antibiotics, macrolide: Azithromycin$111M in FY 2025-263004.20.49Medicaments — containing other antibiotics, tetracyclines: Other$73M in FY 2025-263004.20.12Medicaments — containing other antibiotics, cephalosporins and their derivatives: Cephalexin$56M in FY 2025-263004.20.39Medicaments — containing other antibiotics, fluoroquinolones: Other$47M in FY 2025-263004.20.33Medicaments — containing other antibiotics, fluoroquinolones: Ciprofloxacin$47M in FY 2025-263004.20.20Medicaments — containing other antibiotics: Sulfonamides and Cotrimoxazole$36M in FY 2025-263004.20.13Medicaments — containing other antibiotics, cephalosporins and their derivatives: Ciprofloxacin$34M in FY 2025-263004.20.63Medicaments — containing other antibiotics, macrolide: Clarithromycin$34M in FY 2025-263004.20.96Medicaments — containing other antibiotics, other: Vancomycin$30M in FY 2025-263004.20.95Medicaments — containing other antibiotics, other: Clindamycin$26M in FY 2025-26